LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

Home・Stock List・Becton Dickinson and Co

Becton Dickinson and Co

Closed

Sector Healthcare

232.6 -0.17

Buy Sell

Overview

Share price change

24h

Current

Min

232.41

Max

233.91

Key metrics
By Trading Economics
Income	-50M 487M
Sales	10M 5.1B
P/E Sector Avg	50.04 103.001
EPS	3.5
Profit margin	9.625
Employees	73,000
EBITDA	-124M 1.2B

Recommendations
By TipRanks
Recommendations	Strong Buy
12 Months Forecast	+20.64 upside

Dividends
By Dow Jones
Next Earnings	7 Nov 2024
Next Dividend date	30 Sept 2024
Next Ex Dividend date	9 Sept 2024

Market Stats
By TradingEconomics
Market Cap	70B
Previous open	232.77
Previous close	232.6

News Sentiment

By Acuity

91%

8 / 365 Healthcare

Technical Score

By Trading Central

Confidence

Very Strong Bearish Evidence

N/A / 236.38 Support & Resistance

Becton Dickinson and Co Chart

Related News

1 Aug 2024, 11:08 UTC

Earnings

Becton 3Q Adjusted Earnings Top Views But International Sales Weigh on FY24 Outlook

3 Jun 2024, 11:18 UTC

Acquisitions, Mergers, Takeovers

Becton Dickinson to Acquire Edwards Lifesciences' Critical Care Product Group for $4.2 Billion in Cash

2 May 2024, 11:07 UTC

Earnings

Becton Dickinson Shakes Up 2024 Outlook After Growing 2Q Sales, Earnings

1 Aug 2024, 10:37 UTC

Earnings

Becton Dickinson Now Sees FY24 Revenue About $20.1B; Had Seen $20.1B-$20.3B >BDX

1 Aug 2024, 10:35 UTC

Earnings

Becton Dickinson Sees FY24 Revenue Up About 3.7%, Organic Revenue Up 5%-5.25% >BDX

1 Aug 2024, 10:35 UTC

Earnings

Becton Dickinson Sees FY24 Adj EPS $13.05-Adj EPS $13.15 >BDX

1 Aug 2024, 10:30 UTC

Earnings

Becton Dickinson 3Q EPS $1.68 >BDX

1 Aug 2024, 10:30 UTC

Earnings

Becton Dickinson 3Q Net $487M >BDX

1 Aug 2024, 10:30 UTC

Earnings

Becton Dickinson 3Q Adj EPS $3.50 >BDX

1 Aug 2024, 10:30 UTC

Earnings

Becton Dickinson 3Q Rev $5B >BDX

4 Jun 2024, 17:26 UTC

Acquisitions, Mergers, Takeovers

Edwards Lifesciences Deal A Clear Win For Becton Dickinson, Analysts Say -- Analysis

3 Jun 2024, 15:30 UTC

Hot Stocks

Stocks to Watch Monday: GameStop, AMC, Paramount, Nvidia -- WSJ

3 Jun 2024, 13:26 UTC

Acquisitions, Mergers, Takeovers

Edwards Lifesciences Stock Nears Breakout On A Surprise $4.2 Billion Deal -- IBD

3 Jun 2024, 12:25 UTC

Peer Comparison

Price change

Becton Dickinson and Co Forecast

Price Target

By TipRanks

20.64% upside

12 Months Forecast

Average 280.7 USD 20.64%

High 312 USD

Low 255 USD

Based on 11 Wall Street analysts offering 12 month price targets forBecton Dickinson and Co - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

11 ratings

Buy

Hold

Sell

Based on 11 analysts giving stock ratings to Becton Dickinson and Co - Dist in the past 3 months.

Technical Score

By Trading Central

N/A / 236.38Support & Resistance

Recent bearish events outweigh bullish events.

All events are bearish.

Sentiment

By Acuity

8 / 365 Healthcare

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

About Becton Dickinson and Co

Becton, Dickinson and Company (BD) is a global medical technology company engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic products. The Company operates through segments such as BD Medical, BD Life Sciences and BD Interventional. The BD Medical segment produces an array of medical technologies and devices that are used to help improve healthcare delivery in a range of settings. BD Medical consists of various business units, including medication delivery solutions, medication management solutions, diabetes care and pharmaceutical systems. The BD Life Sciences segment provides products for the safe collection and transport of diagnostics specimens, and instruments and reagent systems to detect a range of infectious diseases, healthcare-associated infections and cancers. The BD Interventional segment provides vascular, urology, oncology and surgical specialty products.